Cangrelor: Phase III started

MDCO started the double-blind, Plavix-controlled, international Phase III CHAMPION PCI trial of cangrelor in 9,000 patients. Plavix clopidogrel is marketed by Bristol-Myers Squibb Co. (BMY, New York,...